Fridriksdottir Hafrun

Executive VP, Global R&D

1 company

Average

Trades Analyzed

12M Win Rate

28.6%

Avg 3M Return

-10.0%

Avg 12M Return

-10.6%

Fridriksdottir Hafrun is an Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $50K based on current market prices.

Holdings by Company

TEVAMay 17, 2022

Current Shares1.4K

Value$50.3K

Net Activity-379,061

Bought: 0Sold: 379.1K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
Feb 9, 2021	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	29,496	$12.69	$374,436.97	-11.6%
Mar 17, 2020	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	514	$7.16	$3,682.04	-0.6%
Feb 14, 2020	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	11,472	$12.14	$139,295.32	-10.4%
Feb 10, 2020	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	5,544	$12.27	$68,024.88	-14.3%
Dec 31, 2019	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	2,459	$9.92	$24,396.23	-9.8%
Dec 2, 2019	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	4,310	$10.49	$45,214.49	-17.3%
Mar 18, 2019	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	356	$16.63	$5,918.54	-1.0%
Mar 4, 2019	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	409	$16.88	$6,905.27	-2.5%
Feb 14, 2019	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	1,841	$17.67	$32,528.63	-10.7%
Jan 2, 2019	TEVA Teva Pharmaceutical Industries Ltd	Executive VP, Global R&D	Sale+OE	1,643	$15.70	$25,799.21	-12.2%